Doxium® : Chronic venous insufficiency - Diabetic retinopathy
Philosophy
History
Worldwide activity
R & D
Manufacturing
Products
Marketing Authorizations
International Availability
Main Products
-
Broncho-Vaxom
-
Dicynone
- Doxium
-
Uro-Vaxom
Other Products
-
Doxiproct
-
Doxiproct Plus
-
Gynazole
-
Sinomarin
Health and Diseases
News
Contacts
Careers and jobs
Forum
homepage
>
products
>
doxium
>
c
omposition
Composition
Active principle: calcium dobesilate
Capsule: calcium dobesilate 500 mg. Colour. (E 132), excipients for capsule.
Tablet: calcium dobesilate 250 mg. Antiox. (E 223), excipients for tablet.
Properties/Effects
Composition
Pharmacokinetics
Indications
Dosage and administration
Limitations for use
Adverse effects
Interactions
Overdosage
Particular remarks
Presentation
Mechanism of action
List of publications
Contact us
back home
